アスパラギナーゼ市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00008224
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 176
Buy Now

アスパラギナーゼ市場は、2021 年の 5 億 6,401 万米ドルから 2028 年までに 15 億 7,562 万米ドルに成長すると予想されています。2022 年から 2028 年にかけて 16.1% の CAGR で成長すると推定されています。

アスパラギナーゼはアスパラギンを分解する酵素です。アスパラギナーゼは、急性リンパ芽球性白血病 (ALL)、リンパ芽球性リンパ腫 (LBL)、およびその他の特定の血液がんを治療するための化学療法薬として使用されます。正常な細胞とは異なり、ALL 細胞はアスパラギンを作ることができません。したがって、アスパラギナーゼはがん細胞の分裂と増殖を停止します。アスパラギナーゼは、大腸菌、エルウィニア クリサンテミ、ペグ化アスパラギナーゼ、菌類、藻類などに由来します。

世界のアスパラギナーゼ市場は、種類、用途、最終用途産業、および地理に基づいて分割されています。地理的には、市場は北米、ヨーロッパ、アジア太平洋、中東、およびアジア太平洋に大きく分類されます。アフリカ、そして南と南。中米。このレポートは、市場の傾向やダイナミクスなどのパラメーター、および世界をリードする市場プレーヤーの競合分析に重点を置き、市場の洞察と詳細な分析を提供します。

戦略的洞察

世界のアスパラギナーゼ市場にとって有利な地域

市場洞察

製薬および食品産業の大幅な成長が世界のアスパラギナーゼ市場を後押し

製薬および食品産業食品産業は著しく発展しており、食品や医薬品の高品質を確保するためにさまざまな発展が見られます。欧州製薬産業・団体連盟によると、2021年の世界の医薬品売上高の49%を北米が占め、2015年から2020年までに新発売された医薬品による売上高の63.7%を占めました。さらに、製薬産業は著しい速度で発展しています。研究開発活動の急増に支えられ、市場関係者による製薬業界への投資の増加が市場をさらに押し上げています。

食品業界は絶え間なく拡大しており、食品は際限なく増加しています。要求。新しい食品も続々と登場しています。現在、メーカーは食品の栄養量に重点を置いています。世界中で揚げ物や焼き食品の消費量が大幅に増加しており、そのような食品への傾向も急増しています。アスパラギナーゼは、カルボニル源が凝縮された揚げ物や焼き食品の糖質を減らす役割を担う主要なアミノ酸です。

タイプ インサイト

タイプに基づいて、世界のアスパラギナーゼ市場は大腸菌に分類されます。 (大腸菌)、エルウィナ・クリサンセミ、ペグ化など。大腸菌セグメントは2021年に市場でより大きなシェアを占めており、このセグメントは、大腸菌由来のアスパラギナーゼの需要の増加により、2022年から2028年の予測期間中に市場で最高のCAGRを記録すると予想されています。 ALL や LBL などのがんの治療。

アスパラギナーゼ由来の大腸菌は、急性リンパ芽球性白血病の治療に使用されます。アスパラギナーゼ大腸菌は、L-アスパラギンを触媒してL-アスパラギン酸とアンモニアを生成する酵素です。細胞の代謝に必要なオキサロ酢酸の生成を助けます。大腸菌由来のアスパラギナーゼには抗腫瘍特性があり、白血病の治療に使用されます。したがって、がん治療、特に小児患者におけるアスパラギナーゼ大腸菌の需要が市場の成長を牽引しています。

タイプ別の世界のアスパラギナーゼ市場 – 2021 年と 2028 年

アプリケーション インサイト

アプリケーションに基づいて、世界のアスパラギナーゼ市場は治療用、食品加工用などに分かれています。 2021 年には治療セグメントが市場で大きなシェアを占めており、このセグメントはリンパ増殖性疾患やリンパ腫の治療に使用されるため、市場で最高の CAGR を記録すると予想されています。このセグメントはさらに、急性リンパ芽球性白血病、リンパ芽球性リンパ腫などに分類されます。

急性リンパ芽球性白血病は、血液および骨髄のがんの一種であり、治療しなければ死に至ります。 Institute for Health Metrics and Evaluation によると、2019 年に世界中で約 153,000 人の急性リンパ性白血病の新規症例と 47,600 人の死亡が報告されました。したがって、世界中で急性リンパ性白血病の症例が増加していることが、世界のアスパラギナーゼ市場の成長を推進しています。

< h3>最終用途産業に関する洞察

最終用途に基づいて、世界のアスパラギナーゼ市場はヘルスケアと食品製造に分類されます。 2021年にはヘルスケア部門がより大きな市場シェアを獲得しました。さらに、同部門は2022年から2028年にかけて最高のCAGRを記録すると予想されています。この部門の成長の原動力は、急性リンパ性白血病、リンパ芽球性リンパ腫の増加と研究の増加です。

市場で目撃された無機的な成長戦略は、合併と買収、パートナーシップ、コラボレーションでした。これらの活動により、市場関係者のビジネスと顧客ベースの拡大への道が開かれました。最近の主要な市場動向のいくつかを以下に示します。

  • 2021 年 5 月、Jazz Pharmaceuticals は GW 製薬会社を買収しました。研究開発能力を強化します。この買収は、同社がカンナビノイドベースの処方薬の開発と商品化にも役立つことになる。
  • 2021 年 4 月、Servier は Agios Pharmaceuticals の買収を完了した。商用、臨床、研究段階の腫瘍学のポートフォリオを含む 20 億米ドルを超えるロイヤルティ。この買収により、米国の悪性血液学市場におけるセルヴィエの商業的存在感が強化され、固形腫瘍分野における長期的な成長の可能性がもたらされます。
  • 2018 年 8 月、 Medac GmBH は、FarmaMondo SA と提携して、ロシア、ジョージア、アゼルバイジャン、キルギスタン、ウズベキスタン、モルドバの対象医療提供者を対象としたマネージド アクセス プログラムを通じて Spectrila を独占的に配布します。 FarmaMondo は、急性リンパ芽球性白血病患者の Spectrila へのアクセスを管理します。

世界のアスパラギナーゼ市場で活動している主要企業には、Servier Pharmaceuticals LLC、BioVendor R&D、Creative Enzymes、medac GmbH などがあります。 、Changzhou Qianhong Bio-pharma Co Ltd、United Biotech、Porton Biopharma、Taj Pharmaceuticals Limited、Jazz Pharmaceuticals plc.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Asparaginase?

Asparaginase is an enzyme that breaks down asparagine. Asparaginase is used as a chemotherapy drug to treat acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LBL), and certain other blood cancers. Unlike normal cells, ALL cells are unable to make their own asparagine. Therefore, asparaginase stops the cancer cells from dividing and growing. Asparaginase are derived from Escherichia coli, Erwinia chrysanthemi, pegylated asparaginase, fungi, algae and others.

What are the driving factors for the global asparaginase market across the world?

The factors that are driving the growth of the asparaginase market are rising incidences of leukemia and increasing usage applications and significant growth of the pharmaceutical and food industry are the major factors contributing to the growth of the asparaginase industry.

Who are the major players in the asparaginase market across the globe?

The asparaginase market majorly consists of the players, such as Servier Pharmaceuticals LLC, Jazz Pharmaceuticals plc, BioVendor R&D, Creative Enzymes, medac GmbH, Changzhou Qianhong Bio-pharma Co Ltd, United Biotech, Porton Biopharma, and Taj Pharmaceuticals Limited and among others.

What is the market CAGR value of the asparaginase market during the forecast period?

The CAGR value of the asparaginase market during the forecasted period of 2022-2028 is 16.1%

What is the estimated asparaginase market size in 2021?

The asparaginase market is estimated to be valued at US$ 564.01 million in 2021.

What are the growth estimates for the asparaginase market till 2028?

The asparaginase market is expected to be valued at US$ 1,575.62 million in 2028.

Which segment by type led the asparaginase market?

The Escherichia Coli segment held the largest share of the market in the global asparaginase market contributing a market share of 49.78% in 2021.

Which region is projected to be the fastest-growing region in the global asparaginase market?

The Asia Pacific is expected to be the fastest-growing region in the asparaginase market over the forecast period due to increasing prevalence of acute lymphoblastic leukemia, increasing research activities in cancer, and increasing innovative products for treatment of hematological cancers by the market players in the region.

The List of Companies - Asparaginase Market

  1. Servier Pharmaceuticals LLC
  2. Jazz Pharmaceuticals plc
  3. BioVendor R&D
  4. Creative Enzymes
  5. medac GmbH
  6. Changzhou Qianhong Bio-pharma Co Ltd
  7. United Biotech
  8. Porton Biopharma
  9. Taj Pharmaceuticals Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports